Insys Therapeutics, Inc.·4

Aug 11, 4:41 PM ET

Insys Therapeutics, Inc. 4

4 · Insys Therapeutics, Inc. · Filed Aug 11, 2014

Insider Transaction Report

Form 4
Period: 2014-08-07
BAKER DARRYL S
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2014-08-07+45,00045,000 total
    Exercise: $27.14Exp: 2024-08-06Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on August 7, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION